Concepedia

Satoshi Shimizu

SS

Statistics

Publications

86

Citations

4.8K

H-Index

35

Active since

1966

Affiliations

The University of Osaka(Current)

National Cancer Center Hospital East

Kyoto Medical Center

Shizuoka General Hospital

University of Shizuoka

Satoshi Shimizu is an author at The University of Osaka specializing in medicine, oncology, and pharmacology.

Publications per year

1966–2025

86

Publications

86

Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL.

Satoshi Shimizu, Yawara Eguchi, Wataru Kamiike et al. · PubMed · 1996 · 362 citations

Life Sciences, Cancer Biology, Cell Biology +14

The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

Satoshi Shimizu, Tetsuo Takehara, Hayato Hikita et al. · Journal of Hepatology · 2010 · 342 citations

Life Sciences, Molecular Biology, Oncology +17

Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma

Satoshi Shimizu, Tetsuo Takehara, Hayato Hikita et al. · International Journal of Cancer · 2011 · 260 citations

Medicine, Oncology, Pharmacology +17

Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions.

Satoshi Shimizu, Yawara Eguchi, Wataru Kamiike et al. · PubMed · 1996 · 257 citations

Life Sciences, Biochemistry, Cell Biology +12

Phase I study of sorafenib in Japanese patients with hepatocellular carcinoma

Junji Furuse, Hiroshi Ishii, Kohei Nakachi et al. · Cancer Science · 2007 · 194 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–5 of 86